A new cancer vaccine targeting melanoma, currently the subject of a phase 2 trial, has shown “promising” results, as one researcher tells CURE®.
2024
Advanced Melanoma: Efficacy of Monoclonal Antibody Doublet
In a phase I trial reported in the Journal of Clinical Oncology, Omid Hamid, MD, and colleagues found that the combination of the human lymphocyte activation gene-3 (LAG-3)-targeting monoclonal antibody fianlimab plus the PD-1–targeting monoclonal antibody cemiplimab-rwlc was active in patients with advanced melanoma.
Call for urgent melanoma screening
Australia must implement a national melanoma screening program like those in place for bowel and breast cancer say Queensland health researchers.
Patients failing at melanoma self-checks: Study
Well-meaning patients are putting their lives at risk, with a new study finding most people are unable to self-diagnose skin cancer on their own bodies.